Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic approaches for women predisposed to breast cancer.

Annual review of medicine - 1 Jan 2011

Nathanson Katherine L, Domchek Susan M

Abstract excerpt

The medical management of women at an increased risk of breast cancer has substantially changed over the past few years, with improvements in screening, cancer prevention, and treatment, and is best defined for women with mutations in BRCA1 and BRCA2. Screening techniques, such as breast magnetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fallopian Tubes
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mastectomy

Share to Ovarian Neoplasms

Share to Ovariectomy

Share to Poly(ADP-ribose) Polymerase Inhibitors

Share to Tamoxifen

Source

Identifiers

PMID: 21034216
DOI: 10.1146/annurev-med-010910-110221

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21034216-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic approaches for women predisposed to breast cancer.PMID 21034216Read ↗

Breast cancer in BRCA mutation carriers: medical treatment.Semantic proximity Read ↗

Clinical management of hereditary breast cancer syndromes.Semantic proximity Read ↗

Systemic therapy options in BRCA mutation-associated breast cancer.Semantic proximity Read ↗

Cancer treatment according to BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

New Therapeutic Options for BRCA Mutant PatientsSemantic proximity Read ↗

Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier.Semantic proximity Read ↗

Stumbling Blocks on the Path to Personalized Medicine in Breast Cancer: The Case of PARP Inhibitors for <i>BRCA1/2</i>-Associated CancersSemantic proximity Read ↗

BRCA1/2 testing: therapeutic implications for breast cancer managementSemantic proximity Read ↗

Clinical management of women with genomic BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Targeting the DNA repair pathway for breast cancer therapy: Beyond the molecular subtypesSemantic proximity Read ↗

An overview of the research progress of BRCA gene mutations in breast cancer.Semantic proximity Read ↗

Conservative management of breast cancer in BRCA1/2 mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.